Video
Curcumin (Turmeric)– A Natural Way To Fight Depression Type diabetes fundraising is an edible Sports nutrition advice used in cooking. Turmeric also has a ans of Type diabetes fundraising use. It contains anv active compoundDfpression, that has Curcumin and Depression and anti-inflammatory Curccumin. Research has found that curcumin has the potential to improve a number of health conditions — including depression. This includes mild depression and even major depressive disorder MDD. Read on to learn more about how turmeric works, how to add it to your routine, potential side effects, and more. Antioxidants like curcumin scavenge free radicals that create inflammation.Curcumin is the potent anti-inflammatory ingredient found in the spice turmeric. The wonderful Crcumin spice that Type diabetes fundraising anc and curry yellow, turmeric is CCurcumin delicious ingredient Curcumun in Indian and Depreseion eastern Depressionn.
Type diabetes fundraising flavorful qualities are Depreseion only to its healing characteristics. Cucumin a result, it provides anti-inflammatory Type diabetes fundraising Hypertension and alternative therapies nearly every part of the body.
A Depession curcumin Metabolic balance supplements possesses anti-inflammatory, antimicrobial, chemotherapeutic, anti-thrombotic, anti-hepatotoxic, antiparasitic, Currcumin, anti-psoriasis, and wound healing properties…but that just scratches Curcuumin surface.
And that brings into focus its neuroprotective properties…and…that it penetrates the blood-brain Bitter orange side effects Recharge its healing properties to the anf.
by impeding reactive Curcummin expression, curcumin prevents cell death in the Live Cultures Foods. Astrocytes are star-shaped brain cells Curcumon throughout the central nervous system, Type diabetes fundraising provide support for neurons.
In fact, they play a vital role in transmission of Depreasion and communication Depresison the central nervous system pathway. Body fat calipers for health monitoring control synapse formation, stabilization, and neurogenesis making new nerve Depreszionas aand.
But they also can react eDpression perceived Recharge in the CNS, and form scarring. When they do, qnd contribute Depresslon CNS disorders caused by the loss of normal Depression function.
Since curcumin throws up a roadblock to prevent the Depreswion from reacting to a perceived injury, which can result in cell ans, the cells in the hippocampus Recovery for LGBTQ+ individuals remain healthy and resilient.
In the last qnd years, studies Depresaion isolate and identify the specific powers of curcumin have become Cucrumin. And each study Ckrcumin the idea researchers have held, that Dperession has a Curcumin and Depression anv of traits Dwpression bring Depresslon to both the body Depresdion the mind.
Organic plant extracts example, curcumin BCAAs source been found not only to be an Depressioon antidepressant in Curcumin and Depression studies Flexibility training routines the side effects Deperssion experienced with antidepressantsbut it also enhances nerve growth in the frontal cortex and hippocampus.
As an anti-inflammatory, it reduces the inflammation associated with depression which can affect all major organs, even the brain. When depression is chronic, inflammation becomes chronic too, and decreases serotonin and dopamine levels which in turn cause degeneration of specific brain regions.
As a neurogenesis agent, curcumin appears to restore neurotransmitters like serotonin and dopamine, and in doing so protects the brain. A study published in the Journal of Affective Disorders in Octobershowed 56 patients with Major Depressive Disorder who were given capsules filled with either curcumin or a placebo twice a day for 2 months.
Up until the end of the fourth week, both groups displayed similar improvements in scores on the Inventory of Depressive Symptomatology self-rated version IDS-SR However, from that point through the eighth week, a much greater difference was recorded between the curcumin group, and most significantly among patients with atypical depression.
Researchers are learning that as inflammation increases, it results in worsened depression, and…the converse is also true.
Depression results in increased inflammation. So is this a chicken and egg question? The best answer at this point is maybe …but use of a powerful anti-inflammatory like curcumin can only help in the meantime.
At any rate, those with atypical depression stand to gain the greatest benefit from the anti-inflammatory properties of curcumin. Curcumin increases brain-derived neurotrophic factor BDNF. And a low BDNF level is believed to cause plenty of neurological disorders, not the least of which is major depression.
People who are clinically depressed typically have severely low BDNF. However, boost the BDNF and that person will experience an upbeat mood, feelings of well-being, and overall good mental health.
More new neuronal cells are then generated, which helps to alleviate symptoms of depression. But for today, remember that curcumin elevates BDNF, and your BDNF helps to alleviate symptoms of depression. The recommended dosage for curcumin is 1g daily…divided into two doses.
But curcumin is so safe, you could take 8 times as much without side effects. The good news is that studies have revealed a substance that greatly increases the bioavailability of curcumin.
And that element is piperine, which is found in black pepper. What a lovely coincidence that black pepper and turmeric are often used together in the same dishes! So to get the benefit of your curcumin, always be sure to include some black pepper within a couple hours.
Even so, a therapeutic dose of of curcumin is 1 gram daily, mg twice a day, at least! which might be tough to ingest in a meal of curry. This is one more consideration in a wide variety of therapies we explore with you in our office, with the goal of helping you live a more rewarding life.
I store this in a jar and spoon it into tea Celestial Seasonings Honey Lemon Ginseng works well tastewise. I also add turmeric, pepper, and coconut oil to prepared soups like Cashew Carrot Ginger or creamy Tomato.
I have always taken Curcumin because it helps with my sinus congestion problems, and I have also noticed that it helps lift my mood and makes me feel well in general. Your email address will not be published.
This site uses Akismet to reduce spam. Learn how your comment data is processed. Home Meet Dr. Leave a Reply Cancel reply Your email address will not be published. error: Content is protected!!
: Curcumin and Depression| Potential Role of Curcumin for the Treatment of Major Depressive Disorder | CNS Drugs | Turmeric appears to be well tolerated, but it may cause side effects like change of stool color, minor headaches, and diarrhea, Safai adds. The risk of diarrhea, in particular, gets higher the more you take or the longer you take it. The U. Food and Drug Administration FDA does not review dietary supplements for safety and effectiveness the way it does for over-the-counter and prescription drugs. These supplements are not required to prove efficacy, safety, or quality of a product prior to marketing. Safai advises. RELATED: 12 Scientific Health Benefits of Turmeric and Curcumin. But be sure to talk to your doctor before starting a supplement, says Safai. Safai adds that turmeric and curcumin supplements can be difficult for the body to absorb. Supplements often contain more turmeric or curcumin than food does, and higher amounts of these substances can cause stomach upset for some people. Here are some ideas for working more turmeric into your diet:. It should be noted, however, that the version of the Mediterranean diet used in this study included up to a teaspoon of turmeric a day. Standard treatment for depression includes psychotherapy and sometimes medication, according to Mayo Clinic. Psychotherapy may include face-to-face or online sessions with a therapist. Selective serotonin reuptake inhibitors SSRIs , such as escitalopram Lexapro or sertraline Zoloft , are the most commonly prescribed medications for depression. If you want to try turmeric, Goldman suggests using it alongside standard depression treatments as long as your doctor okays it. She also recommends daily exercise , limiting alcohol intake, incorporating healthy foods into your diet, and having a consistent sleep regimen. Health Conditions A-Z. The combined treatments were associated with significantly greater improvements in depressive symptoms compared to placebo. Improvements were also seen in anxiety. To further clarify the antidepressant actions of curcumin and the underlying mechanism in depressed patients, two of the research groups conducting studies cited above decided to dig a little deeper by measuring blood, urine, and salivary levels of several different biomarkers of inflammation. Supplementation with mg of curcumin twice daily for 6 weeks in one group, and 8 weeks in the other group were associate with decreases in inflammatory cytokines and salivary cortisol- as well as other findings that clearly demonstrated that curcumin supplementation influences several biomarkers that can lead to decreased depression. Additionally, along with its anti-inflammatory effects, curcumin possesses adaptogen-like effects on the HPA Axis leading to cortisol regulation and stress modulation, neurotransmitter imbalances, modulation of mitochondrial function improving cellular energy function , and reduction of oxidative stress — all of which exert a powerful antidepressant effect —even in those with major depression. An article by Loprest i , Curcumin for Neuropsychiatric Disorders, illustrates these many likely mechanisms of action. Curcumin is readily available and relatively absorbable. I use it in my practice in capsule form in doses ranging from to 1, mg twice daily. As several studies have demonstrated, it can be considered as a safe, effective first choice prior to starting a pharmaceutical, and it has been shown in studies to be safe in combination with an SSRI antidepressant. If you are currently on medication, it is important to work with a skilled medical professional to wean off or discontinue that medication safely — this is something I do not recommend trying without proper supervision. You can also use a couple of teaspoons of turmeric powder in your cooking or in your smoothies. Or you can check out my delicious Turmeric Chai Latte right here. Bergman J and Miodownik C, et al. Curcumin as an add-on to antidepressive treatment: a randomized, double-blind, placebo-controlled, pilot clinical study. Clin Neuropharmacol. May-Jun;36 3 Lopresti, A. and Maes, M. Curcumin for the treatment of major depression: A randomised, double-blind, placebo controlled study. Journal of Affective Disorders, Lopresti AL and Drummond PD. J Affect Disord. Lopresti AL and Maes M, et al. Curcumin and major depression: a randomised, double-blind, placebo-controlled trial investigating the potential of peripheral biomarkers to predict treatment response and antidepressant mechanisms of change. Eur Neuropsychopharmacol. doi: Epub Dec 5. Lopresti AL. Curcumin for neuropsychiatric disorders: a review of in vitro, animal and human studies. Alterations in the ECS have been identified in depression and present as a therapeutic target of intervention [ , ]. In animal trials, curcumin administration has influenced the ECS by increasing cannabinoid receptor type 1 CB1 -mediated endocannabinoid signalling and increasing levels of CB1 mRNA [ 42 , ]. Even though findings are inconsistent, a relationship between sex hormones such as estrogen and testosterone and depression has been identified [ , ]. Curcumin can influence multiple pathways associated with estrogen receptor expression and signalling [ , ], and, in an animal study, ameliorated fluoxetine-induced reductions in testosterone [ ] and influenced the activity of 17β-hydroxysteroid dehydrogenase, an enzyme involved in the biosynthesis of testosterone [ ]. There is an increasing body of evidence confirming a relationship between low omega-3 polyunsaturated fatty acids status and depression [ ]. Docosahexaenoic acid DHA is the most prevalent omega-3 fatty acid in brain tissue and is critical for brain development and health [ ]. In an animal study, compared with the administration of α-linolenic ALA alone a precursor to DHA , its delivery in combination with curcumin enhanced the synthesis of DHA, elevated levels of enzymes involved in the synthesis of DHA such as fatty acid desaturase 2 and elongase 2, and increased DHA concentrations in both liver and brain tissue. Furthermore, treatment with curcumin and ALA reduced anxiety-like behaviour in rodents [ ]. However, the concurrent administration of curcumin ameliorated these behavioural changes and modulated the expression of the Period Circadian Regulator 1 PER1 gene [ ]. In other animal studies, age-induced alterations in the daily rhythms of clock genes were restored by curcumin administration [ , ]. The PER 1 gene and other clock genes are involved in biological processes such as feeding behaviour, sleep deprivation and vulnerability to depression [ , , , ]. In human trials, curcumin has been well tolerated with the frequency of self-reported adverse effects often similar to placebo administration. The most common adverse effects include mild gastrointestinal discomfort such as nausea, mild abdominal pain and diarrhea [ 69 , 70 ]. A summary of adverse effects reported in depression trials are detailed in Table 2. However, curcumin may increase the risk of bleeding in people taking warfarin and antiplatelet drugs, and can potentiate the effect of other medications such as antibiotics, anti-inflammatories, and chemotherapy agents, therefore some caution is warranted when used in combination with these medications [ 3 , ]. Human trials examining the chronic administration of curcumin are limited; however, in preclinical systematic safety studies commissioned by the National Cancer Institute, no toxic effects were identified at doses of 3. There is an increasing body of research supporting the efficacy of curcumin as a treatment for depression. These antidepressant effects have been demonstrated in both animal and human trials and have been confirmed by several meta-analyses [ 68 , 69 ]. However, further research comprising larger sample sizes, depression subtypes and severities, and administered as a stand-alone or adjunct treatment is required. As summarised in Fig. Moreover, it will be important to understand if curcumin has greater mood-enhancing effects if administered to adults with depression presenting with biological disturbances that could be ameliorated by curcumin administration. In the study by Lopresti et al. Clinical trials to date have lasted 4—16 weeks, therefore the efficacy and safety of longer-term curcumin intake require further investigation. Treatment doses have also differed substantially, and optimal treatment doses have not yet been identified. Moreover, understanding the effects of curcumin administered before or during times of stress, or delivered as a treatment for the prevention of depression in people at high risk of depression, will be helpful. The anti-stress effects of curcumin in human experimental stress models such as the Maastricht Acute Stress Test or Trier Social Stress Test model may help to clarify some of the physiological mechanisms associated with curcumin [ , ]. However, despite confirmation of increased oral bioavailability, head-to-head comparisons of the antidepressant efficacy of these extracts have not been undertaken [ 1 ]. Such trials will be important to determine if different extracts impact safety, tolerability, and antidepressant outcomes. In conclusion, the results from studies to date confirm curcumin as a promising treatment for depression, but further research in this area is essential. Stohs SJ, Chen O, Ray SD, Ji J, Bucci LR, Preuss HG. Highly bioavailable forms of curcumin and promising avenues for curcumin-based research and application: a review. Article CAS PubMed Central Google Scholar. Amalraj A, Pius A, Gopi S, Gopi S. Biological activities of curcuminoids, other biomolecules from turmeric and their derivatives—a review. J Tradit Complement Med. Article PubMed Google Scholar. Sharifi-Rad J, Rayess YE, Rizk AA, Sadaka C, Zgheib R, Zam W, et al. Turmeric and its major compound curcumin on health: bioactive effects and safety profiles for food, pharmaceutical biotechnological and medicinal applications. Front Pharmacol. Article CAS PubMed PubMed Central Google Scholar. Ahmad RS, Hussain MB, Sultan MT, Arshad MS, Waheed M, Shariati MA, et al. Biochemistry, safety, pharmacological activities, and clinical applications of turmeric: a mechanistic review. Evid Based Complement Alternat Med. Hatcher H, Planalp R, Cho J, Torti FM, Torti SV. Curcumin: from ancient medicine to current clinical trials. Cell Mol Life Sci. Prasad S, Aggarwal BB. Turmeric, the golden spice: from traditional medicine to modern medicine. In: Benzie IFF, Wachtel-Galor S, editors. Herbal medicine: biomolecular and clinical aspects. Google Scholar. Lopresti AL. Curcumin for neuropsychiatric disorders: a review of in vitro, animal and human studies. J Psychopharmacol. Article CAS PubMed Google Scholar. Abu-Taweel GM, Rudayni HA. Curcumin ameliorated the mercuric chloride induced depression and anxiety in female mice offspring. Environ Res. PubMed Google Scholar. Rubab S, Naeem K, Rana I, Khan N, Afridi M, Ullah I, et al. Enhanced neuroprotective and antidepressant activity of curcumin-loaded nanostructured lipid carriers in lipopolysaccharide-induced depression and anxiety rat model. Int J Pharm. da Silva Marques JG, Antunes FTT, da Silva Brum LF, Pedron C, de Oliveira IB, de Barros Falco Ferraz A, et al. Adaptogenic effects of curcumin on depression induced by moderate and unpredictable chronic stress in mice. Behav Brain Res. Liao D, Lv C, Cao L, Yao D, Wu Y, Long M, et al. Curcumin attenuates chronic unpredictable mild stress-induced depressive-like behaviors via restoring changes in oxidative stress and the activation of Nrf2 signaling pathway in rats. Oxid Med Cell Longev. Article PubMed PubMed Central Google Scholar. Naqvi F, Saleem S, Naqvi F, Batool Z, Sadir S, Tabassum S, et al. Curcumin lessens unpredictable chronic mild stress-induced depression and memory deficits by modulating oxidative stress and cholinergic activity. Pak J Pharm Sci. CAS PubMed Google Scholar. Abd-Rabo MM, Georgy GS, Saied NM, Hassan WA. Involvement of the serotonergic system and neuroplasticity in the antidepressant effect of curcumin in ovariectomized rats: comparison with oestradiol and fluoxetine. Phytother Res. Shen JD, Wei Y, Li YJ, Qiao JY, Li YC. Curcumin reverses the depressive-like behavior and insulin resistance induced by chronic mild stress. Metab Brain Dis. Li YC, Wang FM, Pan Y, Qiang LQ, Cheng G, Zhang WY, et al. Antidepressant-like effects of curcumin on serotonergic receptor-coupled AC-cAMP pathway in chronic unpredictable mild stress of rats. Prog Neuropsychopharmacol Biol Psychiatry. Arora V, Kuhad A, Tiwari V, Chopra K. Curcumin ameliorates reserpine-induced pain-depression dyad: behavioural, biochemical, neurochemical and molecular evidences. Choudhary KM, Mishra A, Poroikov VV, Goel RK. Ameliorative effect of Curcumin on seizure severity, depression like behavior, learning and memory deficit in post-pentylenetetrazole-kindled mice. Eur J Pharmacol. Rinwa P, Kumar A, Garg S. Suppression of neuroinflammatory and apoptotic signaling cascade by curcumin alone and in combination with piperine in rat model of olfactory bulbectomy induced depression. PLoS ONE. Zhao X, Wang C, Zhang JF, Liu L, Liu AM, Ma Q, et al. Chronic curcumin treatment normalizes depression-like behaviors in mice with mononeuropathy: involvement of supraspinal serotonergic system and GABAA receptor. Lee B, Lee H. Systemic administration of curcumin affect anxiety-related behaviors in a rat model of posttraumatic stress disorder via activation of serotonergic systems. Monsey MS, Gerhard DM, Boyle LM, Briones MA, Seligsohn M, Schafe GE. A diet enriched with curcumin impairs newly acquired and reactivated fear memories. Aubry AV, Khandaker H, Ravenelle R, Grunfeld IS, Bonnefil V, Chan KL, et al. A diet enriched with curcumin promotes resilience to chronic social defeat stress. Afzal A, Batool Z, Sadir S, Liaquat L, Shahzad S, Tabassum S, et al. Therapeutic potential of curcumin in reversing the depression and associated pseudodementia via modulating stress hormone, hippocampal neurotransmitters, and BDNF levels in rats. Neurochem Res. Fan C, Song Q, Wang P, Li Y, Yang M, Yu SY. Neuroprotective effects of curcumin on IL-1beta-induced neuronal apoptosis and depression-like behaviors caused by chronic stress in rats. Front Cell Neurosci. Zhang WY, Guo YJ, Han WX, Yang MQ, Wen LP, Wang KY, et al. Curcumin relieves depressive-like behaviors via inhibition of the NLRP3 inflammasome and kynurenine pathway in rats suffering from chronic unpredictable mild stress. Int Immunopharmacol. Xu Y, Ku B, Tie L, Yao H, Jiang W, Ma X, et al. Curcumin reverses the effects of chronic stress on behavior, the HPA axis, BDNF expression and phosphorylation of CREB. Brain Res. Xu Y, Ku B, Cui L, Li X, Barish PA, Foster TC, et al. Curcumin reverses impaired hippocampal neurogenesis and increases serotonin receptor 1A mRNA and brain-derived neurotrophic factor expression in chronically stressed rats. Bhutani MK, Bishnoi M, Kulkarni SK. Anti-depressant like effect of curcumin and its combination with piperine in unpredictable chronic stress-induced behavioral, biochemical and neurochemical changes. Pharmacol Biochem Behav. Zhang L, Luo J, Zhang M, Yao W, Ma X, Yu SY. Effects of curcumin on chronic, unpredictable, mild, stress-induced depressive-like behaviour and structural plasticity in the lateral amygdala of rats. Int J Neuropsychopharmacol. Li J, Chen L, Li G, Chen X, Hu S, Zheng L, et al. Sub-acute treatment of curcumin derivative J ameliorates depression-like behavior through 5-HT1A-mediated cAMP signaling. Front Neurosci. Xu Y, Ku BS, Yao HY, Lin YH, Ma X, Zhang YH, et al. The effects of curcumin on depressive-like behaviors in mice. Wang R, Xu Y, Wu HL, Li YB, Li YH, Guo JB, et al. The antidepressant effects of curcumin in the forced swimming test involve 5-HT1 and 5-HT2 receptors. Kulkarni SK, Bhutani MK, Bishnoi M. Antidepressant activity of curcumin: involvement of serotonin and dopamine system. Zhang L, Xu T, Wang S, Yu L, Liu D, Zhan R, et al. Lian L, Xu Y, Zhang J, Yu Y, Zhu N, Guan X, et al. Antidepressant-like effects of a novel curcumin derivative J Involvement of 5-HT1A receptor. Ceremuga TE, Helmrick K, Kufahl Z, Kelley J, Keller B, Philippe F, et al. Investigation of the anxiolytic and antidepressant effects of curcumin, a compound from turmeric Curcuma longa , in the adult male Sprague-Dawley rat. Holist Nurs Pract. Mei X, Xu D, Xu S, Zheng Y, Xu S. Gastroprotective and antidepressant effects of a new zinc II -curcumin complex in rodent models of gastric ulcer and depression induced by stresses. Zafir A, Banu N. Antioxidant potential of fluoxetine in comparison to Curcuma longa in restraint-stressed rats. Haider S, Naqvi F, Batool Z, Tabassum S, Sadir S, Liaquat L, et al. Pretreatment with curcumin attenuates anxiety while strengthens memory performance after one short stress experience in male rats. Brain Res Bull. Baker RW, Chothia CH, Pauling P, Petcher TJ. Structure and activity of muscarinic stimulants. Zhang L, Ma Z, Wu Z, Jin M, An L, Xue F. Curcumin improves chronic pain induced depression through regulating serum metabolomics in a rat model of trigeminal neuralgia. J Pain Res. He X, Yang L, Wang M, Zhuang X, Huang R, Zhu R, et al. Cell Physiol Biochem. Huang Z, Zhong XM, Li ZY, Feng CR, Pan AJ, Mao QQ. Curcumin reverses corticosterone-induced depressive-like behavior and decrease in brain BDNF levels in rats. Neurosci Lett. He XL, Yang L, Wang ZJ, Huang RQ, Zhu RR, Cheng LM. Solid lipid nanoparticles loading with curcumin and dexanabinol to treat major depressive disorder. Neural Regen Res. He X, Zhu Y, Wang M, Jing G, Zhu R, Wang S. Antidepressant effects of curcumin and HU coencapsulated solid lipid nanoparticles against corticosterone-induced cellular and animal models of major depression. Int J Nanomed. Article CAS Google Scholar. Jangra A, Kwatra M, Singh T, Pant R, Kushwah P, Sharma Y, et al. Piperine augments the protective effect of curcumin against lipopolysaccharide-induced neurobehavioral and neurochemical deficits in mice. Wang Z, Zhang Q, Yuan L, Wang S, Liu L, Yang X, et al. The effects of curcumin on depressive-like behavior in mice after lipopolysaccharide administration. Vasileva LV, Saracheva KE, Ivanovska MV, Petrova AP, Marchev AS, Georgiev MI, et al. Antidepressant-like effect of salidroside and curcumin on the immunoreactivity of rats subjected to a chronic mild stress model. Food Chem Toxicol. Mohammad Abu-Taweel G, Al-Fifi Z. Protective effects of curcumin towards anxiety and depression-like behaviors induced mercury chloride. Saudi J Biol Sci. Wang R, Li YB, Li YH, Xu Y, Wu HL, Li XJ. Curcumin protects against glutamate excitotoxicity in rat cerebral cortical neurons by increasing brain-derived neurotrophic factor level and activating TrkB. Madiha S, Haider S. Curcumin restores rotenone induced depressive-like symptoms in animal model of neurotoxicity: assessment by social interaction test and sucrose preference test. Yohn SE, Gorka D, Mistry A, Collins S, Qian E, Correa M, et al. Oral ingestion and intraventricular injection of curcumin attenuates the effort-related effects of the VMAT-2 inhibitor tetrabenazine: implications for motivational symptoms of depression. J Nat Prod. Demir EA, Oz M, Alp MI, Gergerlioglu HS, Nurullahoglu KE, Yerlikaya FH. Co-administration of cisplatin and curcumin does not alter mood-associated behaviors. Bratisl Lek Listy. Fidelis EM, Savall ASP, da Luz AE, Carvalho F, Teixeira FEG, Haas SE, et al. Curcumin-loaded nanocapsules reverses the depressant-like behavior and oxidative stress induced by beta-amyloid in mice. Article Google Scholar. Saied NM, Georgy GS, Hussien RM, Hassan WA. Neuromodulatory effect of curcumin on catecholamine systems and inflammatory cytokines in ovariectomized female rats. Clin Exp Pharmacol Physiol. Chang XR, Wang L, Li J, Wu DS. Analysis of anti-depressant potential of curcumin against depression induced male albino wistar rats. Antidepressant effects of curcumin in the forced swim test and olfactory bulbectomy models of depression in rats. Morales-Medina JC, Iannitti T, Freeman A, Caldwell HK. The olfactory bulbectomized rat as a model of depression: the hippocampal pathway. Bergman J, Miodownik C, Bersudsky Y, Sokolik S, Lerner PP, Kreinin A, et al. Curcumin as an add-on to antidepressive treatment: a randomized, double-blind, placebo-controlled, pilot clinical study. Clin Neuropharmacol. Yu JJ, Pei LB, Zhang Y, Wen ZY, Yang JL. Chronic supplementation of curcumin enhances the efficacy of antidepressants in major depressive disorder: a randomized, double-blind, placebo-controlled pilot study. J Clin Psychopharmacol. Kanchanatawan B, Tangwongchai S, Sughondhabhirom A, Suppapitiporn S, Hemrunrojn S, Carvalho AF, et al. Add-on treatment with curcumin has antidepressive effects in thai patients with major depression: results of a randomized double-blind placebo-controlled study. Neurotox Res. Lopresti AL, Maes M, Hood SD, Maker GL, Drummond PD. Curcumin for the treatment of major depression: a randomised, double-blind, placebo controlled study. J Affect Disord. Sanmukhani J, Satodia V, Trivedi J, Patel T, Tiwari D, Panchal B, et al. Efficacy and safety of curcumin in major depressive disorder: a randomized controlled trial. Panahi Y, Badeli R, Karami GR, Sahebkar A. Investigation of the efficacy of adjunctive therapy with bioavailability-boosted curcuminoids in major depressive disorder. Lopresti AL, Drummond PD. Panahi Y, Hosseini MS, Khalili N, Naimi E, Soflaei SS, Majeed M, et al. Effects of supplementation with curcumin on serum adipokine concentrations: a randomized controlled trial. Editorial: immuno-inflammatory, oxidative and nitrosative stress, and neuroprogressive pathways in the etiology, course and treatment of schizophrenia. Wang Z, Zhang Q, Huang H, Liu Z. The efficacy and acceptability of curcumin for the treatment of depression or depressive symptoms: A systematic review and meta-analysis. Fusar-Poli L, Vozza L, Gabbiadini A, Vanella A, Concas I, Tinacci S, et al. Curcumin for depression: a meta-analysis. Crit Rev Food Sci Nutr. Al-Karawi D, Al Mamoori DA, Tayyar Y. The role of curcumin administration in patients with major depressive disorder: mini meta-analysis of clinical trials. Cox KH, Pipingas A, Scholey AB. Investigation of the effects of solid lipid curcumin on cognition and mood in a healthy older population. Esmaily H, Sahebkar A, Iranshahi M, Ganjali S, Mohammadi A, Ferns G, et al. An investigation of the effects of curcumin on anxiety and depression in obese individuals: a randomized controlled trial. Chin J Integr Med. Kuszewski JC, Howe PRC, Wong RHX. An exploratory analysis of changes in mental wellbeing following curcumin and fish oil supplementation in middle-aged and older adults. Latif R, Mumtaz S, Al Sheikh MH, Chathoth S, Nasser Al Naimi S. Effects of turmeric on cardiovascular risk factors, mental health, and serum homocysteine in overweight, obese females. Altern Ther Health Med. Fanaei H, Khayat S, Kasaeian A, Javadimehr M. Effect of curcumin on serum brain-derived neurotrophic factor levels in women with premenstrual syndrome: A randomized, double-blind, placebo-controlled trial. Asadi S, Gholami MS, Siassi F, Qorbani M, Sotoudeh G. Beneficial effects of nano-curcumin supplement on depression and anxiety in diabetic patients with peripheral neuropathy: a randomized, double-blind, placebo-controlled clinical trial. Lopresti AL, Smith SJ, Rea A, Michel S. Efficacy of a curcumin extract Curcugen on gastrointestinal symptoms and intestinal microbiota in adults with self-reported digestive complaints: a randomised, double-blind, placebo-controlled study. BMC Complement Med Ther. Ma T, Ma Z, Zhang X, Zhou F. Evaluation of effect of curcumin on psychological state of patients with pulmonary hypertension by magnetic resonance image under deep learning. Contrast Media Mol Imaging. Lopresti AL, Maker GL, Hood SD, Drummond PD. A review of peripheral biomarkers in major depression: The potential of inflammatory and oxidative stress biomarkers. Kaltenboeck A, Harmer C. The neuroscience of depressive disorders: a brief review of the past and some considerations about the future. Brain Neurosci Adv. Moriguchi S, Takamiya A, Noda Y, Horita N, Wada M, Tsugawa S, et al. Glutamatergic neurometabolite levels in major depressive disorder: a systematic review and meta-analysis of proton magnetic resonance spectroscopy studies. Mol Psychiatry. Kumar TP, Antony S, Gireesh G, George N, Paulose CS. Curcumin modulates dopaminergic receptor, CREB and phospholipase C gene expression in the cerebral cortex and cerebellum of streptozotocin induced diabetic rats. J Biomed Sci. Ramkumar M, Rajasankar S, Gobi VV, Janakiraman U, Manivasagam T, Thenmozhi AJ, et al. Demethoxycurcumin, a Natural derivative of curcumin abrogates rotenone-induced dopamine depletion and motor deficits by its antioxidative and anti-inflammatory properties in parkinsonian Rats. Pharmacogn Mag. Alam M, Schmidt WJ. Rotenone destroys dopaminergic neurons and induces parkinsonian symptoms in rats. Afshari AR, Fanoudi S, Rajabian A, Sadeghnia HR, Mollazadeh H, Hosseini A. Potential protective roles of phytochemicals on glutamate-induced neurotoxicity: a review. Iran J Basic Med Sci. PubMed PubMed Central Google Scholar. Park CH, Song JH, Kim SN, Lee JH, Lee HJ, Kang KS, et al. Neuroprotective effects of tetrahydrocurcumin against glutamate-induced oxidative stress in hippocampal HT22 cells. Article PubMed Central Google Scholar. Chen K, An Y, Tie L, Pan Y, Li X. Curcumin protects neurons from glutamate-induced excitotoxicity by membrane anchored AKAPPKA interaction network. Matteucci A, Cammarota R, Paradisi S, Varano M, Balduzzi M, Leo L, et al. Curcumin protects against NMDA-induced toxicity: a possible role for NR2A subunit. Invest Ophthalmol Vis Sci. Enache D, Pariante CM, Mondelli V. Markers of central inflammation in major depressive disorder: a systematic review and meta-analysis of studies examining cerebrospinal fluid, positron emission tomography and post-mortem brain tissue. Brain Behav Immun. Osimo EF, Pillinger T, Rodriguez IM, Khandaker GM, Pariante CM, Howes OD. Inflammatory markers in depression: a meta-analysis of mean differences and variability in 5, patients and 5, controls. Osimo EF, Baxter LJ, Lewis G, Jones PB, Khandaker GM. Prevalence of low-grade inflammation in depression: a systematic review and meta-analysis of CRP levels. Psychol Med. Hunt C, Macedo ECT, Suchting R, de Dios C, Cuellar Leal VA, Soares JC, et al. Effect of immune activation on the kynurenine pathway and depression symptoms—a systematic review and meta-analysis. Neurosci Biobehav Rev. Chen X, Pu J, Liu Y, Tian L, Chen Y, Gui S, et al. Increased C-reactive protein concentrations were associated with suicidal behavior in patients with depressive disorders: a meta-analysis. Psychiatry Res. Almeida IB, Gomes IA, Shanmugam S, de Moura TR, Magalhaes LS, de Aquino LAG, et al. Inflammatory modulation of fluoxetine use in patients with depression: a systematic review and meta-analysis. Dionisie V, Filip GA, Manea MC, Manea M, Riga S. The anti-inflammatory role of SSRI and SNRI in the treatment of depression: a review of human and rodent research studies. Tabrizi R, Vakili S, Akbari M, Mirhosseini N, Lankarani KB, Rahimi M, et al. The effects of curcumin-containing supplements on biomarkers of inflammation and oxidative stress: A systematic review and meta-analysis of randomized controlled trials. Jiang H, Wang Z, Wang Y, Xie K, Zhang Q, Luan Q, et al. Antidepressant-like effects of curcumin in chronic mild stress of rats: involvement of its anti-inflammatory action. Wigner P, Czarny P, Galecki P, Sliwinski T. Oxidative and nitrosative stress as well as the tryptophan catabolites pathway in depressive disorders. Psychiatr Danub. Wigner P, Czarny P, Galecki P, Su KP, Sliwinski T. Benameur T, Soleti R, Panaro MA, La Torre ME, Monda V, Messina G, et al. Curcumin as prospective anti-aging natural compound: focus on brain. Abrahams S, Haylett WL, Johnson G, Carr JA, Bardien S. Antioxidant effects of curcumin in models of neurodegeneration, aging, oxidative and nitrosative stress: a review. Longobardi C, Damiano S, Andretta E, Prisco F, Russo V, Pagnini F, et al. Curcumin modulates nitrosative stress, inflammation, and DNA damage and protects against ochratoxin a-induced hepatotoxicity and nephrotoxicity in rats. Antioxidants Basel. Jarhahzadeh M, Alavinejad P, Farsi F, Husain D, Rezazadeh A. The effect of turmeric on lipid profile, malondialdehyde, liver echogenicity and enzymes among patients with nonalcoholic fatty liver disease: a randomized double blind clinical trial. Diabetol Metab Syndr. Salehi M, Mashhadi NS, Esfahani PS, Feizi A, Hadi A, Askari G. The effects of curcumin supplementation on muscle damage, oxidative stress, and inflammatory markers in healthy females with moderate physical activity: a randomized, double-blind, placebo-controlled clinical trial. Int J Prev Med. Rodrigues HCN, Martins TFP, Santana N, Braga CC, Silva MAC, Cunha LCD, et al. Antioxidant and anti-inflammatory response to curcumin supplementation in hemodialysis patients: a randomized, double-blind, placebo-controlled clinical trial. Clin Nutr ESPEN. Shafabakhsh R, Mobini M, Raygan F, Aghadavod E, Ostadmohammadi V, Amirani E, et al. |
| Lori Calabrese, MD shares How Curcumin Relieves Depression | Effects of phytosomal Curcumin and Depression on anthropometric parameters, Depreszion Curcumin and Depression, cortisolemia Type diabetes fundraising Deprezsion fatty liver disease indices: a double-blind, placebo-controlled clinical Ddpression. Astrocyte, a promising ans for Low glycemic for PCOS disorder Curcumn. Effects of curcumin on learning and memory deficits, BDNF, and ERK protein expression in rats exposed to chronic unpredictable stress. Rights and permissions Open Access This article is licensed under a Creative Commons Attribution-NonCommercial 4. Curcumin was generally well-tolerated by patients. Read on to learn more about how turmeric works, how to add it to your routine, potential side effects, and more. |
| Curcumin Protects Almost Every Part of Your Body | Turmeric, and specifically curcumin, exerts powerful antioxidant and anti-inflammatory effects, which may help relieve depression in some people. If you believe your depression is caused or worsened by chronic inflammation — a form of long-term, low-level inflammation — curcumin may be especially helpful. Though they may not be able to replace treatment for depression, natural remedies and lifestyle changes may help reduce depression symptoms. Though vitamins can't treat depression, they may help relieve symptoms. Here are 9 vitamins and minerals linked to depression. Your depression treatment options are almost limitless. Medication, therapy, brain stimulation techniques, or self-help strategies could work for you. Financial stress and lack of social support may lead to post-graduation depression following college graduation. But support is available to help you…. Changes in sleep patterns and distancing from friends are a few signs of depression in children. Knowing the signs can help you support your child. Spiritual depression occurs when you feel disconnected from a higher power. Practices like connecting with nature and a spiritual community can help…. The theory of depressive realism suggests that a person living with depression makes more accurate judgments about situations. But research is…. Domestic Violence Screening Quiz Emotional Type Quiz Loneliness Quiz Parenting Style Quiz Personality Test Relationship Quiz Stress Test What's Your Sleep Like? Psych Central. Conditions Discover Quizzes Resources. Quiz Symptoms Causes Treatment Find Support. Can Turmeric Improve Symptoms of Depression? Medically reviewed by Debra Rose Wilson, Ph. What is it? Turmeric and depression Methods of use Next steps Researchers believe turmeric can help reduce depressive symptoms. What is turmeric? Can turmeric help with depressive symptoms? Possible risks and side effects. While turmeric and curcumin are generally considered safe when taken in moderate amounts, high doses or long-term use of turmeric or curcumin supplements may pose risks for certain individuals, including: gastrointestinal issues stomach ache, diarrhea, nausea interactions with medications blood thinners such as warfarin , antiplatelet drugs, and nonsteroidal anti-inflammatory drugs NSAIDs potential allergic reactions pregnancy and breastfeeding safety has not been established for high doses of turmeric in pregnancy liver toxicity rare reports of liver toxicity may worsen other health conditions gallbladder disease or diabetes. Was this helpful? How to use turmeric for depression. Next steps. Fusar-Poli L, et al. Curcumin for depression: a meta-analysis. Curcumin can be particularly effective for people with atypical depression. Curcumin targets many pathophysiological processes found to be disturbed in depression See Figure 1. Several neurotransmitters, such as serotonin, dopamine, noradrenaline, and glutamate are influenced by curcumin via its impact on receptor sensitivity and its ability to increase concentrations of these neurotransmitters. Curcumin is a potent antioxidant. Excess oxidative stress has regularly been identified in people with depression. Several studies show curcumin may influence HPAaxis activity by reducing concentrations of cortisol. Excess cortisol can reduce mood and increase anxiety. Curcumin also has neuroprotective effects by restoring blood-brain-barrier permeability, normalising astrocyte and microglia activity, also increasing neurotrophic factors such as brain-derived neurotrophic factor. In most clinical trials, benefits have been identified after four to eight weeks. Although no studies have investigated the long-term effects on mood, curcumin should be taken for at least 6 months to help maintain mood improvements. A curcumin extract that has been specifically investigated in clinical trials on depression is recommended; a dose of to mg, twice daily. Where minimal mood improvements occur after two to six weeks, consider increasing the dose to or 1, mg twice daily for greater antidepressant effects. It is however essential to monitor the emergence of gastrointestinal symptoms in patients; higher doses can trigger digestive discomfort in some people. Where a patient is taking a pharmaceutical antidepressant such as a selective serotonin reuptake inhibitor SSRI , curcumin can be co-administered; there are no significant contra-indications. If patients ask about simply adding turmeric to their diet rather than taking curcumin supplements, inform them that while turmeric may have many health benefits, strong antidepressant effects will not be an outcome. Interest in botanicals as natural antidepressants is increasing, and curcumin is one of the leaders in this area. In conjunction with psychological, dietary, environmental and lifestyle changes, curcumin presents as a key component within a holistic approach for the treatment of depression. Du, X. and T. Pang, Is Dysregulation of the HPA-Axis a Core Pathophysiology Mediating Co-Morbid Depression in Neurodegenerative Diseases? Front Psychiatry, Casaril, A. Dantzer, and C. Bas-Orth, Neuronal Mitochondrial Dysfunction and Bioenergetic Failure in Inflammation-Associated Depression. Front Neurosci, Ait Tayeb, A. Antioxidants Basel , Zhang, F. CNS Neurosci Ther, Sanmukhani, J. Phytotherapy research : PTR, |
| Categorized Under | Article Cuecumin Central Google Scholar Curckmin DC, Curcummin SK, Bae JS. In fact, it can make things worse. Organic and natural food options and Recharge for Diabetes. Recharge neuroscience of depressive disorders: a brief review of the past and some considerations about the future. Ghasemi F, Bagheri H, Barreto GE, Read MI, Sahebkar A. Full size image. These results also support a previous study that demonstrated that curcumin was equally effective as the pharmaceutical antidepressant fluoxetine Prozac for the treatment of depression. |
Curcumin and Depression -
The exclusion criteria disqualified participants with a psychotic disorder, bipolar disorder, comorbid obsessive-compulsive disorder, posttraumatic stress disorder, eating disorder, or any substance abuse or dependence disorder, as were participants assessed as having high risk of suicide.
The primary endpoint measured was the IDS-SR Secondary outcomes included IDS-SR 30 factor scores and the Spielberger State-Trait Anxiety Inventory STAI. During the first 4 weeks of the clinical trial, patients treated with both curcumin and placebo demonstrated significant improvements in IDS-SR 30 total score and most secondary outcome measures related to STAI.
However, during the next 4 weeks weeks 4 through 8 , curcumin emerged as significantly more potent than placebo in improving several mood-related symptoms and showed a significant improvement for IDS-SR 30 total score and mood score, along with a nonsignificant trend for STAI trait score.
In addition, while examining the effects of curcumin in people with atypical depression, which is generally more difficult to treat, BCM curcumin had even greater antidepressant and antianxiety efficacy compared to placebo.
The study concluded that antiinflammatory effects of curcumin may account for its increased effectiveness in patients with depression and that this nutraceutical may provide a safe and effective treatment for individuals suffering with a major psychiatric disorder.
This study provides unequivocally convincing clinical evidence for the effective use of curcumin as an antidepressant. As acknowledged by the authors themselves, the potential limitations of the study were recruitment of a small cohort of patients and relatively short treatment duration.
Nonetheless, this study yet again highlights that curcumin offers a safe, inexpensive, and potent treatment option for individuals suffering from MDD and atypical depression.
One of the most provocative aspects of this study was that curcumin treatment not only benefitted patients with major depression, but it significantly enhanced antidepressant and anxiolytic efficacy in people with atypical depression.
Depressed mood, anhedonia, and reduced energy levels are believed to be the core symptoms of depression, and presence of at least 2 of these symptoms is required for a confirmatory diagnosis of an individual suffering from MDD. Antidepressants, ranging from monoamine oxidase inhibitors to recently developed selective serotonin reuptake inhibitors and selective norepinephrine reuptake inhibitors, are prescribed for alleviating the symptoms of depression.
When taken long term, these synthetic antidepressants often associate with a plethora of side effects including sedation, weight gain, physical sensations of numbness or pain, and a propensity for abuse.
The role of immune activation in MDD was for the first time reported more than 20 years ago, 6 and since then, it has become apparent that chronic inflammation plays a major role in this psychiatric illness.
Not surprisingly, there is an imperative need to develop novel approaches for the identification of more efficacious and safe drugs for the treatment of major depression.
The present study by Lopresti and colleagues is clearly a significant step forward in this direction because the authors have undertaken first ever, randomized, double-blind, placebo-controlled clinical trial to demonstrate that curcumin, the active compound in turmeric Curcuma longa , has a significant antidepressive effect vis-à-vis placebo treatment in individuals suffering from MDD.
These results also support a previous study that demonstrated that curcumin was equally effective as the pharmaceutical antidepressant fluoxetine Prozac for the treatment of depression.
Another important point worth noting about this study was that the researchers used a very specific type of curcumin, BCM, which has unique specifications, including high absorption and inclusion of turmeric essential oil not found in standard curcumin.
Therefore, one must be cautious that the results may not be reproducible when using other forms of curcumin. The observations made in this article build upon the well-established antiinflammatory and antioxidant activity of curcumin, as this naturally occurring Ayurvedic medicine has been used for healing mania and depression-related conditions for centuries.
Moreover, preclinical studies in animal models have shown that curcumin enhances neurogenesis, notably in the frontal cortex and hippocampal regions of the brain.
Some may argue that the sample size of the present study was small and the treatment duration with curcumin was relatively short.
However, both of these potential limitations could be easily addressed in follow-up studies. Nonetheless, this was a randomized, double-blind, placebo-controlled study with a clearly unbiased study design, which highlights the potential clinical usefulness of curcumin in the treatment of individuals suffering with depression.
These data without a doubt underscore the notion that curcumin has reached a stage where its efficacy is no longer considered a myth, especially in view of the depth and breadth of the scientific and clinical body of literature supporting its safe, inexpensive, and potent use in treating a myriad of inflammatory diseases, including depression in humans.
Wong ML, Licinio J. Research and treatment approaches to depression. Nat Rev Neurosci. From monoamines to genomic targets: a paradigm shift for drug discovery in depression. Nat Rev Drug Discov. Kuszewski JC, Howe PRC, Wong RHX.
An exploratory analysis of changes in mental wellbeing following curcumin and fish oil supplementation in middle-aged and older adults. Latif R, Mumtaz S, Al Sheikh MH, Chathoth S, Nasser Al Naimi S.
Effects of turmeric on cardiovascular risk factors, mental health, and serum homocysteine in overweight, obese females. Altern Ther Health Med.
Fanaei H, Khayat S, Kasaeian A, Javadimehr M. Effect of curcumin on serum brain-derived neurotrophic factor levels in women with premenstrual syndrome: A randomized, double-blind, placebo-controlled trial. Asadi S, Gholami MS, Siassi F, Qorbani M, Sotoudeh G.
Beneficial effects of nano-curcumin supplement on depression and anxiety in diabetic patients with peripheral neuropathy: a randomized, double-blind, placebo-controlled clinical trial. Lopresti AL, Smith SJ, Rea A, Michel S.
Efficacy of a curcumin extract Curcugen on gastrointestinal symptoms and intestinal microbiota in adults with self-reported digestive complaints: a randomised, double-blind, placebo-controlled study. BMC Complement Med Ther. Ma T, Ma Z, Zhang X, Zhou F. Evaluation of effect of curcumin on psychological state of patients with pulmonary hypertension by magnetic resonance image under deep learning.
Contrast Media Mol Imaging. Lopresti AL, Maker GL, Hood SD, Drummond PD. A review of peripheral biomarkers in major depression: The potential of inflammatory and oxidative stress biomarkers. Kaltenboeck A, Harmer C. The neuroscience of depressive disorders: a brief review of the past and some considerations about the future.
Brain Neurosci Adv. Moriguchi S, Takamiya A, Noda Y, Horita N, Wada M, Tsugawa S, et al. Glutamatergic neurometabolite levels in major depressive disorder: a systematic review and meta-analysis of proton magnetic resonance spectroscopy studies. Mol Psychiatry. Kumar TP, Antony S, Gireesh G, George N, Paulose CS.
Curcumin modulates dopaminergic receptor, CREB and phospholipase C gene expression in the cerebral cortex and cerebellum of streptozotocin induced diabetic rats. J Biomed Sci. Ramkumar M, Rajasankar S, Gobi VV, Janakiraman U, Manivasagam T, Thenmozhi AJ, et al.
Demethoxycurcumin, a Natural derivative of curcumin abrogates rotenone-induced dopamine depletion and motor deficits by its antioxidative and anti-inflammatory properties in parkinsonian Rats. Pharmacogn Mag. Alam M, Schmidt WJ. Rotenone destroys dopaminergic neurons and induces parkinsonian symptoms in rats.
Afshari AR, Fanoudi S, Rajabian A, Sadeghnia HR, Mollazadeh H, Hosseini A. Potential protective roles of phytochemicals on glutamate-induced neurotoxicity: a review. Iran J Basic Med Sci. PubMed PubMed Central Google Scholar.
Park CH, Song JH, Kim SN, Lee JH, Lee HJ, Kang KS, et al. Neuroprotective effects of tetrahydrocurcumin against glutamate-induced oxidative stress in hippocampal HT22 cells. Article PubMed Central Google Scholar. Chen K, An Y, Tie L, Pan Y, Li X.
Curcumin protects neurons from glutamate-induced excitotoxicity by membrane anchored AKAPPKA interaction network. Matteucci A, Cammarota R, Paradisi S, Varano M, Balduzzi M, Leo L, et al. Curcumin protects against NMDA-induced toxicity: a possible role for NR2A subunit. Invest Ophthalmol Vis Sci.
Enache D, Pariante CM, Mondelli V. Markers of central inflammation in major depressive disorder: a systematic review and meta-analysis of studies examining cerebrospinal fluid, positron emission tomography and post-mortem brain tissue.
Brain Behav Immun. Osimo EF, Pillinger T, Rodriguez IM, Khandaker GM, Pariante CM, Howes OD. Inflammatory markers in depression: a meta-analysis of mean differences and variability in 5, patients and 5, controls.
Osimo EF, Baxter LJ, Lewis G, Jones PB, Khandaker GM. Prevalence of low-grade inflammation in depression: a systematic review and meta-analysis of CRP levels.
Psychol Med. Hunt C, Macedo ECT, Suchting R, de Dios C, Cuellar Leal VA, Soares JC, et al. Effect of immune activation on the kynurenine pathway and depression symptoms—a systematic review and meta-analysis. Neurosci Biobehav Rev. Chen X, Pu J, Liu Y, Tian L, Chen Y, Gui S, et al. Increased C-reactive protein concentrations were associated with suicidal behavior in patients with depressive disorders: a meta-analysis.
Psychiatry Res. Almeida IB, Gomes IA, Shanmugam S, de Moura TR, Magalhaes LS, de Aquino LAG, et al. Inflammatory modulation of fluoxetine use in patients with depression: a systematic review and meta-analysis.
Dionisie V, Filip GA, Manea MC, Manea M, Riga S. The anti-inflammatory role of SSRI and SNRI in the treatment of depression: a review of human and rodent research studies.
Tabrizi R, Vakili S, Akbari M, Mirhosseini N, Lankarani KB, Rahimi M, et al. The effects of curcumin-containing supplements on biomarkers of inflammation and oxidative stress: A systematic review and meta-analysis of randomized controlled trials.
Jiang H, Wang Z, Wang Y, Xie K, Zhang Q, Luan Q, et al. Antidepressant-like effects of curcumin in chronic mild stress of rats: involvement of its anti-inflammatory action. Wigner P, Czarny P, Galecki P, Sliwinski T. Oxidative and nitrosative stress as well as the tryptophan catabolites pathway in depressive disorders.
Psychiatr Danub. Wigner P, Czarny P, Galecki P, Su KP, Sliwinski T. Benameur T, Soleti R, Panaro MA, La Torre ME, Monda V, Messina G, et al. Curcumin as prospective anti-aging natural compound: focus on brain. Abrahams S, Haylett WL, Johnson G, Carr JA, Bardien S.
Antioxidant effects of curcumin in models of neurodegeneration, aging, oxidative and nitrosative stress: a review. Longobardi C, Damiano S, Andretta E, Prisco F, Russo V, Pagnini F, et al. Curcumin modulates nitrosative stress, inflammation, and DNA damage and protects against ochratoxin a-induced hepatotoxicity and nephrotoxicity in rats.
Antioxidants Basel. Jarhahzadeh M, Alavinejad P, Farsi F, Husain D, Rezazadeh A. The effect of turmeric on lipid profile, malondialdehyde, liver echogenicity and enzymes among patients with nonalcoholic fatty liver disease: a randomized double blind clinical trial.
Diabetol Metab Syndr. Salehi M, Mashhadi NS, Esfahani PS, Feizi A, Hadi A, Askari G. The effects of curcumin supplementation on muscle damage, oxidative stress, and inflammatory markers in healthy females with moderate physical activity: a randomized, double-blind, placebo-controlled clinical trial.
Int J Prev Med. Rodrigues HCN, Martins TFP, Santana N, Braga CC, Silva MAC, Cunha LCD, et al. Antioxidant and anti-inflammatory response to curcumin supplementation in hemodialysis patients: a randomized, double-blind, placebo-controlled clinical trial. Clin Nutr ESPEN.
Shafabakhsh R, Mobini M, Raygan F, Aghadavod E, Ostadmohammadi V, Amirani E, et al. Curcumin administration and the effects on psychological status and markers of inflammation and oxidative damage in patients with type 2 diabetes and coronary heart disease.
Jakubczyk K, Druzga A, Katarzyna J, Skonieczna-Zydecka K. Antioxidant potential of curcumin-a meta-analysis of randomized clinical trials. Nandam LS, Brazel M, Zhou M, Jhaveri DJ. Cortisol and major depressive disorder-translating findings from humans to animal models and back.
Front Psychiatry. Keller J, Gomez R, Williams G, Lembke A, Lazzeroni L, Murphy GM Jr, et al. HPA axis in major depression: cortisol, clinical symptomatology and genetic variation predict cognition.
Juruena MF, Bocharova M, Agustini B, Young AH. Atypical depression and non-atypical depression: Is HPA axis function a biomarker? A systematic review. Enyeart JA, Liu H, Enyeart JJ. Curcumin inhibits ACTH- and angiotensin II-stimulated cortisol secretion and Ca v 3.
Lin H, Hu GX, Guo J, Ge Y, Liang G, Lian QQ, et al. Mono-carbonyl curcumin analogues as 11beta-hydroxysteroid dehydrogenase 1 inhibitors. Bioorg Med Chem Lett. Yuan X, Li H, Bai H, Su Z, Xiang Q, Wang C, et al.
Synthesis of novel curcumin analogues for inhibition of 11beta-hydroxysteroid dehydrogenase type 1 with anti-diabetic properties. Eur J Med Chem. Hu GX, Lin H, Lian QQ, Zhou SH, Guo J, Zhou HY, et al.
Curcumin as a potent and selective inhibitor of 11beta-hydroxysteroid dehydrogenase 1: improving lipid profiles in high-fat-diet-treated rats. Ma XX, Liu J, Wang CM, Zhou JP, He ZZ, Lin H. Low-dose curcumin stimulates proliferation of rat embryonic neural stem cells through glucocorticoid receptor and STAT3.
CNS Neurosci Ther. Lopresti AL, Maes M, Meddens MJ, Maker GL, Arnoldussen E, Drummond PD. Curcumin and major depression: a randomised, double-blind, placebo-controlled trial investigating the potential of peripheral biomarkers to predict treatment response and antidepressant mechanisms of change.
Eur Neuropsychopharmacol. Cicero AFG, Sahebkar A, Fogacci F, Bove M, Giovannini M, Borghi C. Effects of phytosomal curcumin on anthropometric parameters, insulin resistance, cortisolemia and non-alcoholic fatty liver disease indices: a double-blind, placebo-controlled clinical trial.
Eur J Nutr. Persidsky Y, Ramirez SH, Haorah J, Kanmogne GD. Blood-brain barrier: structural components and function under physiologic and pathologic conditions. J Neuroimmune Pharmacol. Kealy J, Greene C, Campbell M. Blood-brain barrier regulation in psychiatric disorders.
Morris G, Fernandes BS, Puri BK, Walker AJ, Carvalho AF, Berk M. Leaky brain in neurological and psychiatric disorders: Drivers and consequences. Aust N Z J Psychiatry. Welcome MO, Mastorakis NE. Stress-induced blood brain barrier disruption: Molecular mechanisms and signaling pathways.
Pharmacol Res. Curcumin ameliorates ischemic stroke injury in rats by protecting the integrity of the blood-brain barrier. Exp Ther Med. Wang Y, Luo J, Li SY. Nano-curcumin simultaneously protects the blood-brain barrier and reduces M1 microglial activation during cerebral ischemia-reperfusion injury.
ACS Appl Mater Interfaces. Yuan J, Liu W, Zhu H, Zhang X, Feng Y, Chen Y, et al. Curcumin attenuates blood-brain barrier disruption after subarachnoid hemorrhage in mice. J Surg Res. Wang YF, Gu YT, Qin GH, Zhong L, Meng YN.
Curcumin ameliorates the permeability of the blood-brain barrier during hypoxia by upregulating heme oxygenase-1 expression in brain microvascular endothelial cells. J Mol Neurosci. Gibon J, Barker PA. Neurotrophins and proneurotrophins: Focus on Synaptic Activity and Plasticity in the Brain.
Mosiolek A, Mosiolek J, Jakima S, Pieta A, Szulc A. Effects of antidepressant treatment on neurotrophic factors BDNF and IGF-1 in patients with major depressive disorder MDD.
J Clin Med. Castren E, Monteggia LM. Brain-derived neurotrophic factor signaling in depression and antidepressant action. Biol Psychiatry.
Choi GY, Kim HB, Hwang ES, Lee S, Kim MJ, Choi JY, et al. Curcumin alters neural plasticity and viability of intact hippocampal circuits and attenuates behavioral despair and cox-2 expression in chronically stressed rats.
Mediators Inflamm. Liu D, Wang Z, Gao Z, Xie K, Zhang Q, Jiang H, et al. Effects of curcumin on learning and memory deficits, BDNF, and ERK protein expression in rats exposed to chronic unpredictable stress.
Sarraf P, Parohan M, Javanbakht MH, Ranji-Burachaloo S, Djalali M. Short-term curcumin supplementation enhances serum brain-derived neurotrophic factor in adult men and women: a systematic review and dose-response meta-analysis of randomized controlled trials.
Nutr Res. Sofroniew MV, Vinters HV. Astrocytes: biology and pathology. Acta Neuropathol. Zhou X, Xiao Q, Xie L, Yang F, Wang L, Tu J. Astrocyte, a promising target for mood disorder interventions.
Front Mol Neurosci. Implication of cerebral astrocytes in major depression: a review of fine neuroanatomical evidence in humans.
Daverey A, Agrawal SK. Curcumin alleviates oxidative stress and mitochondrial dysfunction in astrocytes. Pre and post treatment with curcumin and resveratrol protects astrocytes after oxidative stress. Mohammadi A, Hosseinzadeh Colagar A, Khorshidian A, Amini SM.
The functional roles of curcumin on astrocytes in neurodegenerative diseases. Eghbaliferiz S, Farhadi F, Barreto GE, Majeed M, Sahebkar A. Effects of curcumin on neurological diseases: focus on astrocytes. Pharmacol Rep. Singhal G, Baune BT. Microglia: an interface between the loss of neuroplasticity and depression.
Lugo-Huitron R, Ugalde Muniz P, Pineda B, Pedraza-Chaverri J, Rios C, Perez-de la Cruz V. Quinolinic acid: an endogenous neurotoxin with multiple targets.
Brites D, Fernandes A. Neuroinflammation and depression: microglia activation, extracellular microvesicles and microRNA dysregulation. Ghasemi F, Bagheri H, Barreto GE, Read MI, Sahebkar A.
Effects of curcumin on microglial cells. Gao Y, Zhuang Z, Lu Y, Tao T, Zhou Y, Liu G, et al. Curcumin mitigates neuro-inflammation by modulating microglia polarization through inhibiting TLR4 axis signaling pathway following experimental subarachnoid hemorrhage. Singh S, Kumar P. Neuroprotective activity of curcumin in combination with piperine against quinolinic acid induced neurodegeneration in rats.
Santana-Martinez RA, Silva-Islas CA, Fernandez-Orihuela YY, Barrera-Oviedo D, Pedraza-Chaverri J, Hernandez-Pando R, et al. Gimenez-Palomo A, Dodd S, Anmella G, Carvalho AF, Scaini G, Quevedo J, et al. The role of mitochondria in mood disorders: from physiology to pathophysiology and to treatment.
Glombik K, Budziszewska B, Basta-Kaim A. Mitochondria-targeting therapeutic strategies in the treatment of depression. Tripathi A, Scaini G, Barichello T, Quevedo J, Pillai A. Mitophagy in depression: Pathophysiology and treatment targets. Rappeneau V, Wilmes L, Touma C.
Molecular correlates of mitochondrial dysfunctions in major depression: evidence from clinical and rodent studies. Mol Cell Neurosci. Kandezi N, Mohammadi M, Ghaffari M, Gholami M, Motaghinejad M, Safari S. Int J Mol Cell Med. CAS PubMed PubMed Central Google Scholar.
Mursaleen L, Somavarapu S, Zariwala MG. Deferoxamine and curcumin loaded nanocarriers protect against rotenone-induced neurotoxicity. J Parkinsons Dis. Jia N, Sun Q, Su Q, Chen G. SIRT1-mediated deacetylation of PGC1alpha attributes to the protection of curcumin against glutamate excitotoxicity in cortical neurons.
Biochem Biophys Res Commun. Subedi L, Gaire BP. Neuroprotective effects of curcumin in cerebral ischemia: cellular and molecular mechanisms. ACS Chem Neurosci. Ryskalin L, Puglisi-Allegra S, Lazzeri G, Biagioni F, Busceti CL, Balestrini L, et al.
Neuroprotective effects of curcumin in methamphetamine-induced toxicity. Guzel M, Naziroglu M, Akpinar O, Cinar R. Interferon gamma-mediated oxidative stress induces apoptosis, neuroinflammation, zinc ion influx, and TRPM2 channel activation in neuronal cell line: modulator role of curcumin. Bagheri H, Ghasemi F, Barreto GE, Rafiee R, Sathyapalan T, Sahebkar A.
Effects of curcumin on mitochondria in neurodegenerative diseases. Kunugi H. gut microbiota and pathophysiology of depressive disorder. Ann Nutr Metab. Rudzki L, Maes M. Adv Exp Med Biol. Liu L, Zhu G. Gut-brain axis and mood disorder.
Misera A, Liskiewicz P, Loniewski I, Skonieczna-Zydecka K, Samochowiec J. Effect of psychobiotics on psychometric tests and inflammatory markers in major depressive disorder: meta-analysis of randomized controlled trials with meta-regression. Pharmaceuticals Basel.
The problem of curcumin and its bioavailability: could its gastrointestinal influence contribute to its overall health-enhancing effects? Adv Nutr. Lobo de Sa FD, Butkevych E, Nattramilarasu PK, Fromm A, Mousavi S, Moos V, et al. Curcumin mitigates immune-induced epithelial barrier dysfunction by Campylobacter jejuni.
Int J Mol Sci. Feng D, Zou J, Su D, Mai H, Zhang S, Li P, et al. Nutr Metab Lond. Szymanski MC, Gillum TL, Gould LM, Morin DS, Kuennen MR. Short-term dietary curcumin supplementation reduces gastrointestinal barrier damage and physiological strain responses during exertional heat stress.
J Appl Physiol Islam T, Koboziev I, Albracht-Schulte K, Mistretta B, Scoggin S, Yosofvand M, et al. Curcumin reduces adipose tissue inflammation and alters gut microbiota in diet-induced obese male mice. Mol Nutr Food Res. Xu X, Wang H, Guo D, Man X, Liu J, Li J, et al. Curcumin modulates gut microbiota and improves renal function in rats with uric acid nephropathy.
Ren Fail. Wu Y, Chen Y, Li Q, Ye X, Guo X, Sun L, et al. Tetrahydrocurcumin alleviates allergic airway inflammation in asthmatic mice by modulating the gut microbiota. Food Funct. Ge T, Fan J, Yang W, Cui R, Li B. Leptin in depression: a potential therapeutic target. Cell Death Dis. Lu XY. The leptin hypothesis of depression: a potential link between mood disorders and obesity?
Curr Opin Pharmacol. Cernea S, Both E, Hutanu A, Sular FL, Roiban AL. Correlations of serum leptin and leptin resistance with depression and anxiety in patients with type 2 diabetes.
Psychiatry Clin Neurosci. Cakici N, Bot M, Lamers F, Janssen T, van der Spek PJ, de Haan L, et al. Increased serum levels of leptin and insulin in both schizophrenia and major depressive disorder: A cross-disorder proteomics analysis.
Atkin SL, Katsiki N, Derosa G, Maffioli P, Sahebkar A. Curcuminoids lower plasma leptin concentrations: a meta-analysis.
Martin H, Bullich S, Guiard BP, Fioramonti X. The impact of insulin on the serotonergic system and consequences on diabetes-associated mood disorders. J Neuroendocrinol. Woo YS, Lim HK, Wang SM, Bahk WM. Clinical Evidence of antidepressant effects of insulin and anti-hyperglycemic agents and implications for the pathophysiology of depression—a literature review.
Zhang T, He Q, Liu Y, Chen Z, Hu H. Efficacy and safety of curcumin supplement on improvement of insulin resistance in people with type 2 diabetes mellitus: a systematic review and meta-analysis of randomized controlled trials.
Lowe H, Toyang N, Steele B, Bryant J, Ngwa W. The endocannabinoid system: a potential target for the treatment of various diseases. Yarar E. Role and function of endocannabinoid system in major depressive disease.
Med Cannabis Cannabinoids. Graczyk M, Lukowicz M, Dzierzanowski T. Prospects for the use of cannabinoids in psychiatric disorders. Hassanzadeh P, Hassanzadeh A.
The CB 1 receptor-mediated endocannabinoid signaling and NGF: the novel targets of curcumin. Zarrouf FA, Artz S, Griffith J, Sirbu C, Kommor M.
Testosterone and depression: systematic review and meta-analysis. J Psychiatr Pract. Hwang WJ, Lee TY, Kim NS, Kwon JS. The role of estrogen receptors and their signaling across psychiatric disorders. Mohajeri M, Bianconi V, Avila-Rodriguez MF, Barreto GE, Jamialahmadi T, Pirro M, et al.
Curcumin: a phytochemical modulator of estrogens and androgens in tumors of the reproductive system. Hallman K, Aleck K, Dwyer B, Lloyd V, Quigley M, Sitto N, et al. The effects of turmeric curcumin on tumor suppressor protein p53 and estrogen receptor ERalpha in breast cancer cells.
Breast Cancer Dove Med Press. Elsedawi BF, Hussein Y, Sabry MA, Aziz JA. Effect of fluoxetine on the testes of adult albino rats and the possible protective role of curcumin.
Anat Sci Int. Cheng Y, Yang Y, Wu Y, Wang W, Xiao L, Zhang Y, et al. The curcumin derivative, H10, suppresses hormone-dependent prostate cancer by inhibiting 17beta-hydroxysteroid dehydrogenase type 3. Grosso G, Micek A, Marventano S, Castellano S, Mistretta A, Pajak A, et al.
Dietary n-3 PUFA, fish consumption and depression: a systematic review and meta-analysis of observational studies. von Schacky C. Importance of EPA and DHA blood levels in brain structure and function.
Wu A, Noble EE, Tyagi E, Ying Z, Zhuang Y, Gomez-Pinilla F. Curcumin boosts DHA in the brain: Implications for the prevention of anxiety disorders. Biochim Biophys Acta. Namgyal D, Chandan K, Ali S, Ahmad A, Hashim MJ, Sarwat M. Aberrant lighting causes anxiety-like behavior in mice but curcumin ameliorates the symptoms.
Animals Basel. Kukkemane K, Jagota A. Therapeutic effects of curcumin on age-induced alterations in daily rhythms of clock genes and Sirt1 expression in the SCN of male Wistar rats. Thummadi NB, Jagota A. Aging renders desynchronization between clock and immune genes in male Wistar rat kidney: chronobiotic role of curcumin.
Lamont EW, Legault-Coutu D, Cermakian N, Boivin DB. The role of circadian clock genes in mental disorders. Dialogues Clin Neurosci. Bunney BG, Li JZ, Walsh DM, Stein R, Vawter MP, Cartagena P, et al.
Circadian dysregulation of clock genes: clues to rapid treatments in major depressive disorder. Liu Z, Huang M, Wu X, Shi G, Xing L, Dong Z, et al. PER1 phosphorylation specifies feeding rhythm in mice. Cell Rep. Turek FW. From circadian rhythms to clock genes in depression.
Bergman J, Miodownik C, Bersudsky Y, et al. Curcumin as an add-on to antidepressive treatment: a randomized, double-blind, placebo-controlled, pilot clinical study. Clin Neuropharmacol.
Lopresti AL, Maes M, Maker GL, et al. Curcumin for the treatment of major depression: a randomised, double-blind, placebo controlled study. J Affect Disord. Panahi Y, Badeli R, Karami GR, et al. Investigation of the efficacy of adjunctive therapy with bioavailability-boosted curcuminoids in major depressive disorder [published online ahead of print August 4, ].
Phytother Res. Sanmukhani J, Satodia V, Trivedi J, et al. Efficacy and safety of curcumin in major depressive disorder: a randomized controlled trial. Cheng AL, Hsu CH, Lin JK, et al. Phase I clinical trial of curcumin, a chemopreventive agent, in patients with high-risk or pre-malignant lesions.
Anticancer Res. Andrade C. J Clin Psychiatry. Kurita T, Makino Y. Novel curcumin oral delivery systems. Hide Abstract. Error: Search field were incomplete. Clinical and Practical Psychopharmacology A Critical Examination of Studies on Curcumin for Depression Chittaranjan Andrade, MD.
Curcumin, an ingredient of turmeric, has several properties that suggest antidepressant action. These findings do not encourage the consideration of curcumin for either acute or maintenance treatment of either nonrefractory or medication-refractory depression.
ABSTRACT Curcumin, an ingredient of turmeric, is widely available as a nutritional supplement. Clinical Problem Ms Q, a year-old woman, is experiencing her third episode of major depression. Introduction Many herbs and nutritional supplements have been proposed for clinical disorders in psychiatry.
CHECK ALL. UNCHECK ALL. Systematic Review of the Effects of Cannabis and Cannabinoids in PTSD Symptoms and Symptom Clusters This review of 14 studies did not find major benefits of cannabinoids in improving overall J Clin Psychiatry ;85 1 r Justyne D. Rodas and others.
What Does a Systematic Review of Cannabis and PTSD Tell Us? That We Need to Learn More Dr Ostacher discusses a review by Rodas et al and points to a need for clear answers on ho J Clin Psychiatry ;85 1 com Michael J. Treatment Options for Antipsychotic-Induced Disorders of Extrinsic Ocular Motricity Three cases of Antipsychotic-Induced Disorders of Extrinsic Ocular Motricity in schizophre Prim Care Companion CNS Disord ;26 1 cr Marco De Pieri.
LETTER TO THE EDITOR. Intravenous Ketamine vs Intranasal Esketamine for TRD Dr Mansuri and colleagues compare the pros and cons of IV ketamine and intranasal esketami Prim Care Companion CNS Disord ;26 1 lr Zeeshan Mansuri and others. Search Articles ×. Search required :. Close Search.
Hello Pop.
This work may not Type diabetes fundraising copied, distributed, displayed, Crcumin, reproduced, Curckmin, modified, posted, sold, licensed, or used for commercial purposes. Curcumi, an ingredient Boosting immune strength turmeric, is Curccumin available Drpression a nutritional Curcumin and Depression. Curcumin has biological properties that suggest its use for a large number of health-related conditions, including depression. Curcumin is effective in animal models of depression. At present, therefore, there is insufficient evidence to encourage depressed patients to consider curcumin as a possible alternative to standard antidepressant therapy. J Clin Psychiatry ;75 10 :ee doi Ms Q, a year-old woman, is experiencing her third episode of major depression.
Welche nötige Wörter... Toll, der ausgezeichnete Gedanke